Abstract
Histopathologic high risk factors are core content in the histopathologic examination of enucleated retinoblastoma. Histopathologic high risk factors indicate that the patient has high risk of tumor spreading and metastasizing and should be given systemic adjuvant chemotherapy. Therefore, histopathologic high risk factors can provide important basis for clinicians to determine treatment plan and serve as the important foundation for clinical trials and studies to validate the proposed criteria. The focus of our discussion includes three aspects as follows. How to evaluate histopathologic high risk factors? Can clinical characteristics be used to predict histopathologic high risk factors? Do histopathologic high risk factors have any hint for intra-arterial chemotherapy? The importance of evaluating histopathologic high risk factors in retinoblastoma is emphasized in this article.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
